Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Nano X Imaging Ltd (NNOX)

  • Business News
  • June 05, 2025, 12:02 UTC
  • 2

Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment

Market reaction Comment Full text

LivaNova PLC (LIVN)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

Market reaction Comment Full text

LINEAGE THERAP (LCTX)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium

Market reaction Comment Full text

Tempest Therapeutics Inc. (TPST)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC

Market reaction Comment Full text

Scholar Rock Holding Corp (SRRK)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

Scholar Rock to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Market reaction Comment Full text

NewAmsterdam Pharma (NAMS)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 3

NewAmsterdam Pharma to Host R&D Day on June 11, 2025

Market reaction Comment Full text

ZimVie Inc. (ZIMV)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

ZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in Japan

Market reaction Comment Full text

Veradigm Inc (MDRX)

  • Business News
  • June 05, 2025, 12:01 UTC
  • 2

Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare

Market reaction Comment Full text

Cocrystal Pharma Inc. (COCP)

  • Business News
  • June 05, 2025, 12:00 UTC
  • 2

Cocrystal Pharma’s Novel Norovirus Antiviral to be Presented at Department of Defense Medical Conference

Market reaction Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Business News
  • June 05, 2025, 12:00 UTC
  • 2

Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107)

Market reaction Comment Full text
  • Previous
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next

Search

News categories

  • Technical Exchange News(9309)
  • Event(407)
  • SEC News(150123)
  • FDA Approval(8569)
  • Company Report(721)
  • Business News(103336)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin